Replies to post #37610 on DNAprint Genomics (DNAG)

[Gcbr]

W2P---I am a long time holder of AMGN. I know the problems
with EPO. I one time posted that super EPO was going to have super problems. From the research I have done it appears the
Beth Isreal had a problem getting anybody to develope super
epo because of the problems. I thought it was a perfect match
when DNAG took on super EPO. I will say I bet that once we
have the markers for EPO/super EPO there will be a couple of
companies that want to know what they are. Hey JMHO LOL

I think your posts are always on target. Thats why I read them.

Take Care
Arch